Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Dienstmann

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Scientific Reports|November 2, 2021
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohortSusana Cedres, Juan-David Assaf, Patricia Iranzo, et al.
JCO Global Oncology|January 12, 2021
Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in BrazilBruno L Ferrari, Carlos Gil Ferreira, Márcia Menezes, et al.
Gastroenterology|October 12, 2014
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomesFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.
Genome Medicine|March 30, 2018
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterationsDavid Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2020
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reductionNeda Stjepanovic, Guillermo Villacampa, Kevin T Nead, et al.
JCO Precision Oncology|April 3, 2026
Clinical Response to Poly(ADP-ribose) Polymerase Inhibitor in Metastatic Breast Cancer With a Germline Reduced-Penetrance BRCA2 Pathogenic Variant: A Molecular Tumor Board DiscussionDiocésio Alves Pinto de Andrade, Carlos Alberto Fruet Filho, Cristiane Alves Mendes, et al.
Molecular Cancer Therapeutics|June 23, 2012
Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trialsRodrigo Dienstmann, Danila Serpico, Jordi Rodon, et al.
European Radiology|September 10, 2020
Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysisMarta Ligero, Olivia Jordi-Ollero, Kinga Bernatowicz, et al.
Cancer Discovery|June 10, 2020
RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA RegulonJohnny Yu, Albertas Navickas, Hosseinali Asgharian, et al.
British Journal of Cancer|July 24, 2024
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancerNeil H Segal, Jeanne Tie, Scott Kopetz, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Scientific Reports|November 2, 2021
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohortSusana Cedres, Juan-David Assaf, Patricia Iranzo, et al.
JCO Global Oncology|January 12, 2021
Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in BrazilBruno L Ferrari, Carlos Gil Ferreira, Márcia Menezes, et al.
Gastroenterology|October 12, 2014
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomesFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.
Genome Medicine|March 30, 2018
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterationsDavid Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2020
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reductionNeda Stjepanovic, Guillermo Villacampa, Kevin T Nead, et al.
JCO Precision Oncology|April 3, 2026
Clinical Response to Poly(ADP-ribose) Polymerase Inhibitor in Metastatic Breast Cancer With a Germline Reduced-Penetrance BRCA2 Pathogenic Variant: A Molecular Tumor Board DiscussionDiocésio Alves Pinto de Andrade, Carlos Alberto Fruet Filho, Cristiane Alves Mendes, et al.
Molecular Cancer Therapeutics|June 23, 2012
Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trialsRodrigo Dienstmann, Danila Serpico, Jordi Rodon, et al.
European Radiology|September 10, 2020
Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysisMarta Ligero, Olivia Jordi-Ollero, Kinga Bernatowicz, et al.
Cancer Discovery|June 10, 2020
RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA RegulonJohnny Yu, Albertas Navickas, Hosseinali Asgharian, et al.
British Journal of Cancer|July 24, 2024
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancerNeil H Segal, Jeanne Tie, Scott Kopetz, et al.
Pageof 18